A clinical trial on the interaction between aliskiren and furosemide in patients with heart failure.

Registry ID

EUCTR2008-006156-22

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Novartis Pharma Services AG

Start date

2010-02-22

Completion date

2011-08-16

Last update

2026-08-16

Conditions

• Essential hypertension

Summary

•To assess the effect of single (150 mg) and multiple (150 mg and 300 mg) doses of aliskiren on the diuretic efficacy (efficacy index) of 80 mg furosemide at steady state.

Locations

• , , Lithuania
• , , Germany

View on source registry